{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T19:09:09Z","timestamp":1648840149116},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,11,15]]},"DOI":"10.2169\/internalmedicine.4869-20","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T22:07:16Z","timestamp":1595887636000},"page":"2915-2919","source":"Crossref","is-referenced-by-count":1,"title":["Retroperitoneal Metastasis, with Marked Fibrosis, of Lung Adenocarcinoma after Afatinib Treatment: An Autopsy Case Report"],"prefix":"10.2169","volume":"59","author":[{"given":"Hiroki","family":"Ota","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Japanese Red Cross Society, Omori Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Japanese Red Cross Society, Omori Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Narisawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Japanese Red Cross Society, Omori Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Japanese Red Cross Society, Omori Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Surgery, Japanese Red Cross Society, Omori Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Tsukumo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Japanese Red Cross Society, Omori Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Japanese Red Cross Society, Omori Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Honma","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toho University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Quint LE, Tummala S, Brisson LJ, et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg 62: 246-250, 1996.","DOI":"10.1016\/0003-4975(96)00220-2"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 367: 241-251, 2006.","DOI":"10.1016\/S0140-6736(06)68035-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Thomas MH, Chisholm GD. Retroperitoneal fibrosis associated with malignant disease. Br J cancer 28: 453-458, 1973.","DOI":"10.1038\/bjc.1973.171"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kodama K, Imao T, Komatsu K. Metastatic ureteral involvement of non-small cell lung cancer. Hindawi Publishing Corporation Caase Reports in Medicine 1-3, 2011.","DOI":"10.1155\/2011\/394326"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nishiyama A, Yoshioka H, Ikeo S, et al. Retroperitoneal metastasis from lung adenocarcinoma mimics retroperitoneal fibrosis. J Thorac Oncol 11: 266-267, 2015.","DOI":"10.1016\/j.jtho.2015.10.023"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rosenberg S, Katz R, Pode D, Gofrit O, Pizov G, Hovav N. An ALK translocation positive carcinoma of the lung presenting as uremia due to bilateral renal obstruction. Can Urol Assoc J 7: e490-e494, 2013.","DOI":"10.5489\/cuaj.172"},{"key":"7","unstructured":"7. Foureur N, Descamps V, Lebrun-Vignes B, et al. Retroperitoneal fibrosis secondary to metastatic neoplasm revealed by a leg lymphedema. Ann Dermatol Venereol 129: 422-423, 2002 (in French, Abstract in English)."},{"key":"8","unstructured":"8. Mart\u00ednez Vea A, Darnell A, Quesada E, Ferrer-Roca O, Revert L. Malignant retroperitoneal fibrosis associated with pulmonary carcinoma. A review of the literature. Med Clin (Barc) 79: 129-132, 1982 (in Spanish, Abstract in English)."},{"key":"9","unstructured":"9. Mota JM, Sousa LG, Riechelmann RP. Complocations from carcinoid syndrome: review of the current evidence. <i>e<\/i>cancer 662: 1-17, 2016."},{"key":"10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/1759-7714.12484","volume":"8","author":"S Xu","year":"2017","unstructured":"10. Xu S, Liu X, Liu R, et al. Concurrent epidermal growth factor receptor T790M secondary mutation and epithelial-mesenchymal transition in a lung adenocarcinoma patient with EGFR-TKI drug resistance. Thoracic Cancer 8: 693-697, 2017.","journal-title":"Thoracic Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/1759-7706","issn-type":"print"},{"key":"11","unstructured":"11. Liu Y. Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: a case report and literatures review. Cancer Biol Ther 19: 445-459, 2018."},{"key":"12","unstructured":"12. Oser MG, Niederst MJ, Sequist LV, Engelman JA. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol 16: e165-e172, 2015."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kong M, Sung JY, Lee SH. Osimertinib for secondary T790M-mutation-positive squamous cell carcinoma transformation after afatinib failure. J Thorac Oncol 13: e252-e254, 2018.","DOI":"10.1016\/j.jtho.2018.07.100"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ricciuti B, Metro G, Brambilla M, et al. Acquired resistance to afatinib due to T790M-positive squamous progression in EGFR-mutant adenosquamous lung carcinoma. J Thorac Oncol 13: e9-e12, 2018.","DOI":"10.1016\/j.jtho.2017.08.025"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/22\/59_4869-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T03:51:55Z","timestamp":1605930715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/22\/59_4869-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,15]]},"references-count":14,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4869-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,15]]}}}